Education. Communication. Business Consulting.



UCB is a global biopharma focused on severe diseases with operations in about 40 countries and global revenue of € 3.2 billion in 2011. UCB combine biology and chemistry to make major breakthroughs. By integrating their expertise in large, antibody-based molecules and small, chemically-derived molecules, UCB can offer families with severe diseases and their specialist physicians the advantages of both large and small molecules to produce extraordinary breakthroughs.

Next Event

View all events
Tuesday, 29th April 2014 @ 6:30pm

Sparking Biotech Innovation in South China: What Role Does Hong Kong Play?

Rayson Huang Theatre, Rayson Huang Theatre, The University of Hong Kong, Pokfulam, Hong Kong

OBR Consulting

Innovative Business Consulting

OBR-Consulting is a unique opportunity for students to gain experience in consultancy projects at the intersection of science, business and entrepreneurship.

Learn more

Contribute to the OBR community - subscribe today for free

Copyright © 2014 Oxbridge Roundtable Ltd - All Rights Reserved